Header Logo

Connection

Paul Carvey to Drug Interactions

This is a "connection" page, showing publications Paul Carvey has written about Drug Interactions.
Connection Strength

0.115
  1. 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes. Eur J Pharmacol. 1998 Apr 17; 347(1):51-6.
    View in: PubMed
    Score: 0.038
  2. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm. Eur J Pharmacol. 1990 Aug 02; 184(1):43-53.
    View in: PubMed
    Score: 0.022
  3. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity. Pharmacol Biochem Behav. 1990 Feb; 35(2):291-300.
    View in: PubMed
    Score: 0.022
  4. Animal models of tardive dyskinesia: their use in the search for new treatment methods. Mod Probl Pharmacopsychiatry. 1983; 21:5-20.
    View in: PubMed
    Score: 0.013
  5. Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology. 2002 May 14; 58(9):1418-22.
    View in: PubMed
    Score: 0.013
  6. Neuroleptic-induced dopamine hyposensitivity. Life Sci. 1984 Apr 09; 34(15):1475-9.
    View in: PubMed
    Score: 0.004
  7. Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration. Eur J Pharmacol. 1982 Mar 12; 78(3):335-43.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.